Skip to Content Skip to Content

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2720 Results
How Eve Higginbotham is dismantling racist and sexist systems one step at a time
Eve Higginbotham

Eve J. Higginbotham, vice dean for Inclusion and Diversity and professor of ophthalmology at the Perelman School of Medicine. (Image: Penn Medicine News)

How Eve Higginbotham is dismantling racist and sexist systems one step at a time

Amid nationwide demonstrations calling for the long-overdue dismantling of racist systems and institutions, the vice dean for Inclusion and Diversity and professor of ophthalmolog has been busy sharing her voice and taking action.

From Penn Medicine News

Aging and the costs that come with it
Penn student Darcey Hookway

Aging and the costs that come with it

As a high school student, junior Darcey Hookway spent time volunteering on a dementia ward at a local hospital. “The social aspect of their condition really struck me,” says Hookway, who is from London. “They struggled immensely with social isolation. And now with COVID exacerbating that more than ever, I think that’s a huge detriment to their health.”

Katherine Unger Baillie

Nearly 1 in 10 COVID patients return after leaving emergency department
Person lying on back in hospital bed receiving oxygen via a mask.

Nearly 1 in 10 COVID patients return after leaving emergency department

A new Penn study finds patients with low pulse oximetry readings or fever were more than three times as likely to require hospitalization after their initial discharge, as compared to other COVID patients.

From Penn Medicine News

Researchers discover new molecules for tracking Parkinson’s disease
a chemical structure made of a wavy sheet and bound by a single chemical, represented as large colored balls, along one side

The chemical structure of an alpha-synuclein fibril with an “exemplar” molecule, shown as colored spheres, bound to a previously identified binding site. Researchers at Penn recently demonstrated a new method for screening and identifying molecules computationally that can then be developed into imaging probes for studying proteins that are associated with Parkinson’s disease. (Image: E. James Petersson)

Researchers discover new molecules for tracking Parkinson’s disease

The study describes an innovative approach for identifying and evaluating candidate molecules that can image and track the progression of a wide range of neurodegenerative diseases.

Erica K. Brockmeier